Sigyn Therapeutics SIGY
OTC SIGY
$0.03 -0.01 (-25.00%)
At close: Oct 19, 2026 · 4:00 PM EDT

Sigyn Therapeutics, Inc. (SIGY) EBITDA (2017 - 2025)

Updated

Sigyn Therapeutics (SIGY) posted EBITDA of -$386,529 for Q3 2025, compared with -$807,095 a year earlier.

Analysis

Sigyn Therapeutics, Inc. (SIGY) EBITDA (2017 - 2025) Analysis & Trends

For the trailing twelve months through Sep 30, 2025, EBITDA at Sigyn Therapeutics was -$1.88 million; for FY2024, it came in at -$2.51 million.

  • In prior years, Sigyn Therapeutics' EBITDA was -$2.45 million in FY2023, -$2.14 million in FY2022, -$1.99 million in FY2021 and -$905,134 in FY2020.
  • The Q3 2025 figure stands as the highest quarterly EBITDA since Q4 2020.
  • According to Business Quant data, EBITDA for the three prior quarters was -$469,513 (Q2 2025), -$544,696 (Q1 2025) and -$476,647 (Q4 2024).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 -266,790.00
Jun 30, 2025 -388,496.00
Mar 31, 2025 -450,343.00
Dec 31, 2024 -516,734.00
Sep 30, 2024 -1.46 Mn
Jun 30, 2024 -459,168.00
Mar 31, 2024 -545,050.00
Dec 31, 2023 -1.16 Mn
Sep 30, 2023 -861,652.00
Jun 30, 2023 -868,535.00
Mar 31, 2023 -1.31 Mn
Dec 31, 2022 -806,049.00
Sep 30, 2022 -679,403.00
Jun 30, 2022 -638,773.00
Mar 31, 2022 -658,889.00
Dec 31, 2021 -670,186.00
Sep 30, 2021 -621,779.00
Jun 30, 2021 -623,047.00
Mar 31, 2021 -442,258.00
Dec 31, 2020 -399,401.00
API Access

Sigyn Therapeutics, Inc. EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda&ticker=SIGY&period=max&api_key=YOUR_API_KEY